Literature DB >> 20238220

Pure red cell aplasia and primary antiphospholipid syndrome: a unique association.

Cezar Augusto Muniz Caldas1, Jozélio Freire de Carvalho.   

Abstract

Pure red cell aplasia (PRCA) is a disease with important relationships to autoimmune mechanisms. Although some autoimmune diseases, such as rheumatoid arthritis and systemic lupus erythematosus, have been associated with PRCA, until this point no studies have described the association between PRCA and primary antiphospholipid syndrome (APS). This is the first case report of PRCA associated with primary APS in a 39-year-old man with acute heart failure secondary to an anaemic condition that was diagnosed as pure red cell aplasia. The patient was later diagnosed with retinal artery and vein thromboses and bilateral deep venous thromboses of the femoral and popliteal veins. The most common causes of PRCA and other thrombophilias were ruled out in this investigation through complementary tests. This association with APS adds a new possibility to the study of PRCA pathophysiology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20238220     DOI: 10.1007/s00296-010-1387-4

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  11 in total

Review 1.  Autoimmune disorders of erythropoiesis.

Authors:  L Croisille; G Tchernia; N Casadevall
Journal:  Curr Opin Hematol       Date:  2001-03       Impact factor: 3.284

2.  The association of pure red cell aplasia with the antiphospholipid syndrome.

Authors:  T Walton; Y Karim; D Wright; M Khamashta; G Hughes
Journal:  Lupus       Date:  2001       Impact factor: 2.911

Review 3.  Antipsychotic-induced venous thromboembolism: a review of the evidence.

Authors:  Staffan Hägg; Olav Spigset
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

4.  International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).

Authors:  S Miyakis; M D Lockshin; T Atsumi; D W Branch; R L Brey; R Cervera; R H W M Derksen; P G DE Groot; T Koike; P L Meroni; G Reber; Y Shoenfeld; A Tincani; P G Vlachoyiannopoulos; S A Krilis
Journal:  J Thromb Haemost       Date:  2006-02       Impact factor: 5.824

Review 5.  The biology of pure red cell aplasia.

Authors:  E N Dessypris
Journal:  Semin Hematol       Date:  1991-10       Impact factor: 3.851

Review 6.  Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance.

Authors:  P E Love; S A Santoro
Journal:  Ann Intern Med       Date:  1990-05-01       Impact factor: 25.391

7.  [Appearance of central nervous system lupus during corticosteroid therapy and warfarinization in a patient with pure red cell aplasia and antiphospholipid syndrome].

Authors:  Junko Murayama; Yu Asanuma; Tokutarou Tsuda; Junji Nishida; Masato Moriguchi
Journal:  Nihon Rinsho Meneki Gakkai Kaishi       Date:  2006-02

Review 8.  Pure red-cell aplasia: a review.

Authors:  A J Erslev; A Soltan
Journal:  Blood Rev       Date:  1996-03       Impact factor: 8.250

9.  Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case-control study.

Authors:  G L Zornberg; H Jick
Journal:  Lancet       Date:  2000-10-07       Impact factor: 79.321

Review 10.  Haematological toxicity of drugs used in psychiatry.

Authors:  Robert J Flanagan; Louisa Dunk
Journal:  Hum Psychopharmacol       Date:  2008-01       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.